• $7.4M
    Market Cap
  • -29.70%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
01/31/2025
01/31/2024
01/31/2023
01/31/2022
Income Statement
Total Operating Revenue
0
N/A
0
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
0
N/A
N/A
N/A
N/A
N/A
437,689
+135.38%
Research and Development Expense
-424,337
-25.68%
-570,947
-78.67%
-2.7M
-50.61%
-5.4M
+1,803.98%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
260,500
-4.13%
271,731
-3.11%
280,467
-34.14%
425,865
-75.57%
Operating Profit
-5.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-165,087
+262.48%
-45,544
+296.34%
-11,491
-77.80%
-51,761
+634.62%
Interest Income and Expense and Net
-165,087
+262.48%
-45,544
+296.34%
-11,491
-77.80%
-51,761
+634.62%
Total Nonoperating Income and Expense
1.4M
+2,926.15%
45,544
+296.34%
11,491
-77.80%
51,761
+634.62%
Income before Taxes
-3.6M
+24.96%
-2.9M
-69.08%
-9.4M
-22.92%
-12.2M
-66.55%
Income Taxes
0
N/A
0
-100.00%
166,666
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.6M
+24.96%
-2.9M
-69.08%
-9.4M
-22.92%
-12.2M
-66.55%
Net Income from Continuing Operations Applicable to Common
-3.6M
+24.96%
-2.9M
-69.08%
-9.4M
-22.92%
-12.2M
-66.55%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.03
0.00%
-0.03
-70.00%
-0.10
-37.50%
-0.16
-88.06%
Basic Weighted Average Shares
123.9M
+13.34%
109.3M
+26.25%
86.6M
+14.70%
75.5M
+179.24%
Diluted Weighted Average Shares
123.9M
+13.34%
109.3M
+26.25%
86.6M
+14.70%
75.5M
+179.24%
Balance Sheet
Cash and Cash Equivalents
8,180
-78.12%
37,384
+350.03%
8,307
-95.21%
173,513
+12.15%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Cash and Cash Equivalents and Short-Term Investments
8,180
-78.12%
37,384
+350.03%
8,307
-95.21%
173,513
+12.15%
Total Current Assets
8,180
-78.12%
37,384
-49.97%
74,727
-93.46%
1.1M
-14.04%
Accumulated Depreciation
N/A
N/A
N/A
N/A
44,553
+70.58%
26,118
+239.99%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
0
N/A
0
-100.00%
18,435
N/A
0
-100.00%
Total Assets
224,963
-30.73%
324,746
+334.58%
74,727
-93.57%
1.2M
-13.10%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
7.5M
+10.42%
6.8M
-4.48%
7.1M
+72.51%
4.1M
-29.14%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
312,936
+6,903.94%
4,468
N/A
0
-100.00%
353
N/A
Total Liabilities
7.6M
-5.40%
8.0M
+5.42%
7.6M
+50.89%
5.0M
-15.66%
Retained Earnings
-118.6M
+3.06%
-115.1M
+2.58%
-112.2M
-45,070.73%
249,466
+127.52%
Total Stockholders Equity
-7.4M
-4.34%
-7.7M
+2.15%
-7.5M
+94.12%
-3.9M
-15.86%
Total Shares Outstanding
840,000
-98.41%
52.8M
+75.20%
30.1M
-3.58%
31.3M
+2,154.05%
Cash Flow
Cash from Operating Activities
-2.0M
-18.23%
-2.5M
+64.44%
-1.5M
-86.58%
-11.2M
+56.36%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
+100.00%
-71,550
0.00%
-71,550
0.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.0M
-20.35%
2.5M
+87.26%
1.3M
-88.11%
11.2M
+174.68%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-1,317.75%
-9.19%
-1,451.17%
-4.31%
-1,516.52%
+55.76%
-973.60%
+28.39%
Return on Equity
48.11%
+26.38%
38.07%
-76.82%
164.23%
-42.64%
286.33%
-92.30%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.001
-80.00%
0.006
-47.62%
0.01
-96.19%
0.28
+21.33%
Cash Ratio
0.001
-80.00%
0.006
+358.33%
0.001
-97.14%
0.04
+58.11%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow